Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study

BACKGROUND: The contraceptive efficacy and tolerability of a new flexible extended regimen of ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg to extend the menstrual cycle and enable management of intracyclic (breakthrough) bleeding (flexible(MIB)) was investigated and the bleeding pattern comp...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Klipping, Christine, Duijkers, Ingrid, Fortier, Michel P, Marr, Joachim, Trummer, Dietmar, Elliesen, Jörg
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2012
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353880/
https://ncbi.nlm.nih.gov/pubmed/22454003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jfprhc-2011-100213
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak